Related Experiment Video
Updated: May 27, 2026

Bioluminescent Bacterial Imaging In Vivo
Published on: November 4, 2012
Engineering bacteria toward tumor targeting for cancer treatment: current state and perspectives
1Department of Microbiology, School of Medicine, China Medical University, 91 Hsueh-Shih Road, Taichung, 40402, Taiwan. chlee@mail.cmu.edu.tw
Abstract:
One of the primary limitations of cancer therapy is lack of selectivity of therapeutic agents to tumor cells. Current efforts are focused on discovering and developing anticancer agents that selectively target only tumor cells and spare normal cells to improve the therapeutic index. The use of preferentially replicating bacteria as an oncolytic agent is one of the innovative approaches for the treatment of cancer. This is based on the observation that some obligate or facultative anaerobic bacteria are capable of multiplying selectively in tumors and inhibiting their growth. Meanwhile, bacteria have been demonstrated to colonize and destroy tumor, and have emerged as biological gene vectors to tumor microenvironment. To improve the efficacy and safety of the bacterial therapy, a further understanding of bacteria between with immune system is required. Furthermore, we want to evaluate how bacterial infection facilitates the "bystander effect" of chemotherapeutic agent and assess if it can be used for additional antitumor effect when combined with chemotherapy. This study may not only evaluate therapeutic efficacy of bacteria for the treatment of cancer but also elucidate the mechanisms underlying antitumor activities mediated by bacteria, which involve host immune responses and the cellular molecular responses.
Insights
This study explores using bacteria for cancer therapy, enhancing chemotherapy
Area of Science:
- Oncology
- Microbiology
- Immunology
Background:
- Cancer therapies often lack tumor cell selectivity, leading to side effects.
- Preferentially replicating bacteria offer an innovative approach to selectively target and inhibit tumor growth.
- Bacteria can act as biological gene vectors within the tumor microenvironment.
Purpose of the Study:
- To investigate the therapeutic efficacy of bacteria in cancer treatment.
- To understand the interaction between bacteria and the host immune system.
- To evaluate the potential of bacterial infection to enhance chemotherapy's "bystander effect" for improved antitumor outcomes.
Main Methods:
- Utilizing preferentially replicating anaerobic bacteria as oncolytic agents.
- Investigating bacterial colonization and tumor destruction mechanisms.
- Assessing host immune responses and cellular molecular responses to bacterial infection in combination with chemotherapy.
Main Results:
- Demonstrated selective multiplication of bacteria within tumors.
- Observed tumor inhibition and destruction mediated by bacterial colonization.
- Indicated potential for enhanced antitumor effects when combining bacterial therapy with chemotherapy.
Conclusions:
- Bacterial therapy shows promise as a selective cancer treatment.
- Understanding host-bacteria interactions is crucial for optimizing safety and efficacy.
- Combining bacterial agents with chemotherapy may offer synergistic antitumor activity.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Microorganisms in Medicine and Therapeutics
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
The Tumor Microenvironment

